Diagnosis of fatty liver in children should occur in parallel to investigation for other causes of liver disease
Jake P. Mann, Ulli Baumann(Medizinische Hochschule Hannover), Sander Lefere(Ghent University Hospital), Déirdre Kelly(Princess Margaret Cancer Centre), Judith Lubrecht, Anita Vreugdenhil, Wojciech Jańczyk(Children's Memorial Health Institute), Emer Fitzpatrick(King's College London), Jan Melek, Eberhard Lurz, Maria Fotoulaki(Aristotle University of Thessaloniki), Marianne Samyn(King's College Hospital), Aleksander Krag(University of Southern Denmark), Emanuele Nicastro(Ospedale Papa Giovanni XXIII), Benno Kohlmaier(Medical University of Graz), Philip N. Newsome(King's College London), Norman Junge, Corina Pienar(Victor Babeș University of Medicine and Pharmacy Timișoara), Çiğdem Arıkan(Medizinische Hochschule Hannover), Jiří Bronský(Charles University), Anastasia Konidari(University of Liverpool), Ruth De Bruyne(Ghent University Hospital), Giusy Ranucci(University of Naples Federico II), Henedina Antunes, Anna Alisi(Bambino Gesù Children's Hospital), Jernej Brecelj(University of Ljubljana), Bart G.P. Koot(Virginia Commonwealth University), Maria Rogalidou(Unknown), Irene Degrassi, Elvira Verduci(University of Milan), Christos Tzivinikos, Christian Hudert(Charité - Universitätsmedizin Berlin), Thomas Berg(Leipzig University of Applied Sciences), N.Yu. Zavhorodnia, Idoia Labayen(Universidad de Navarra), Kimberley Brook, Virginie Frings, O.Yu. Zavhorodnia, Stephenne Xavier, Giuseppe Indolfi(Meyer Children's Hospital), Tudor Lucian, Aglaia Zellos(National and Kapodistrian University of Athens)
Cited by 27
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877